Dockets Home | Accessibility | Dockets Contacts and Location | Operating Status | Item Codes

DOCKETS ENTERED on 2/3/03

Docket Number - Title

95S-0316 75-Day Premarket Notifications for New Dietary Ingredients*
96P-0215 Withdrawal Norplant's approval for sale in the United States*
99P-4613 Revoke the Regulation That Approved Posilac *
02D-0266 Guidance preventive measures to reduce risk of (CJD)*
02N-0273 Animal Proteins Prohibited in Ruminant Feed *
02N-0445 FDA Regulation of Combination Products; Public Hearing*
02P-0068 Determination of Chymopapain (Chymodiactin) *
02P-0246 Pharmacies of hospitals/other health care entities*
02P-0349 Amend product insert and/or label for Hemophilus Vaccines*
82N-0166 OTC Drug Products for Overindulgence of Alcohol

BKG 1 BACKGROUND MATERIAL Vol#: 8

92N-0297 Prescription Drug Marketing Act of 1987, Drug Amds of 1992

NFR 3 Vol#: 8

95S-0316 75-Day Premarket Notifications for New Dietary Ingredients

M 4 HFS-800 to Stakeholders Vol#: 85

RPT 124 The Remedy Company, Inc. Vol#: 85

RPT 125 Lane Labs-USA Vol#: 85

RPT 126 American Research Institute of World Tra Vol#: 86

RPT 127 Pure Research Products Naturally LLC Vol#: 86

RPT 128 Chemi Nutraceuticals, Inc. Vol#: 87

RPT 129 Herbs Generation International Ltd Vol#: 86

96P-0215 Withdrawal Norplant's approval for sale in the United States

PDN 1 HFD-1 to Population Research Institute Vol#: 6

99N-4282 Biotechnology in the Year 2000 and Beyond; Public Meetings

EMC 3916 Rhiannon Creighton Vol#: 513

EMC 3917 Kelly Hughart Vol#: 513

EMC 3918 Ian Sanders (UK) Vol#: 513

EMC 3919 Stephen Gibson Vol#: 513

EMC 3920 Martha Castillo Vol#: 513

EMC 3921 Cynthia Hood Vol#: 513

EMC 3922 Erica Gray Vol#: 513

EMC 3923 Sheila Stark Vol#: 513

99P-4613 Revoke the Regulation That Approved Posilac

C 1439 Fund for Animals Vol#: 46

00D-1598 Voluntary Labeling for Bioengineered Foods

C 9842 Juliet E. Pressel Vol#: 572

00N-1596 Uniform Compliance Date for Food Labeling Regulations

EC 1 Number Not Used Vol#: 1

00P-1211 Establish Mandatory Pre-Market Safety Testing for GE Foods

EMC 5524 Carolyn Waller Vol#: 785

EMC 5525 Lisa LaBudde Vol#: 785

EMC 5526 Cynthia Woodford Vol#: 785

EMC 5527 William Powers Vol#: 785

EMC 5528 Louis Fox Vol#: 785

EMC 5529 F G Shotz Vol#: 785

EMC 5530 Rosemary Fox Vol#: 785

EMC 5531 Rosemary Fox Vol#: 785

EMC 5532 Lara Pizzorno Vol#: 785

EMC 5533 Scott Puesing Vol#: 785

EMC 5534 Joan Espana Vol#: 785

EMC 5535 Chris Krumm Vol#: 785

EMC 5536 Carol Winkelman Vol#: 785

EMC 5537 Tanya Rampersad Vol#: 785

EMC 5538 Michael Smith Vol#: 785

EMC 5539 Michael Smith Vol#: 785

EMC 5540 Bob DeBolt Vol#: 785

EMC 5541 Bob DeBolt Vol#: 785

EMC 5542 Dan Altman Vol#: 785

EMC 5543 Rhiannon Crieghton Vol#: 785

EMC 5544 Monica Maass Vol#: 785

EMC 5545 Ian Sanders Vol#: 785

EMC 5546 Stephen Gibson Vol#: 785

EMC 5547 Martha Castillo Vol#: 785

EMC 5548 Cynthia Hood Vol#: 785

EMC 5549 Erica Gray Vol#: 785

EMC 5550 Sheila Stark Vol#: 785

01D-0488 Food-Effect Bioavailability & Fed Bioequivalence Studies

GDL 2 GUIDANCE Vol#: 1

NAD 2 Vol#: 1

01N-0275 Performance standard for Diagnostic X-Ray Systems & Major Co

EC 1 Mr. Robert Ward Vol#: 1

01P-0230 Domestic Marketing & Importation of Transgenic Fish

C 1302 Eleanor Whitmore Vol#: 226

C 1303 Erik Ruoff Vol#: 226

C 1304 Josh Ginsberg Vol#: 226

C 1305 Dorothy & Bill Beal Vol#: 226

C 1306 Jay Boyle Vol#: 226

EMC 2662 Carmen Druke Vol#: 228

EMC 2663 Martha Castillo Vol#: 228

02D-0266 Guidance preventive measures to reduce risk of (CJD)

C 19 New York Firefighters Skin Bank Vol#: 1

02N-0253 Withdrawal of 53 Guidances on Individual Product Labeling

EC 18 Number Not Used Vol#: 1

02N-0273 Animal Proteins Prohibited in Ruminant Feed

EC 13 mother Vol#: 2

EC 14 father Vol#: 2

EC 15 Wind Sauna Farms Vol#: 2

EC 16 self Vol#: 2

EC 17 Mr. Edward Bowker Vol#: 2

02N-0445 FDA Regulation of Combination Products; Public Hearing

EC 12 Baxter Healthcare Corporation Vol#: 6

02P-0068 Determination of Chymopapain (Chymodiactin)

LET 2 HFM-17 to ChymoCorp Vol#: 1

02P-0177 Health Claim: D-tagatose and Noncariogenicity

EC 4 Miss chioma anyanwu Vol#: 2

EC 5 Miss Vanessa Cleary Vol#: 2

02P-0246 Pharmacies of hospitals/other health care entities

C 1 Family Care Hlth Centers Pharmacy Dept. Vol#: 1

02P-0349 Amend product insert and/or label for Hemophilus Vaccines

LET 1 HFM-6 to Classen Immunotherapies, Inc. Vol#: 1

03D-0007 Treat Vasomotor/Vulvar/Vaginal Atrophy Symptoms Estrogen

GDL 1 GUIDANCE Vol#: 1

NAD 1 Vol#: 1

03V-0003 Laser light show

VRA 1 HFZ-300 to R. J. Enterprises Vol#: 1

03V-0005 Laser Light Show

VRA 1 HFZ-300 to Baton Rouge Communications Vol#: 1